IngateyGen LLC
Allergen-free peanut developed using CRISPR/Cas genome editing to eliminate clinically documented allergens (Ara h proteins)
- Sector
- Agritech
- Headquarters
- RESEARCH TRIANGLE PARK, NC
- Latest Form D
- $55K, Jul 2024
- Total capital
- $1.7M
- Federal grants
- $1.6M
- 3 awards · 2016–2021
- Rank in peer group#6 of 27
- Private capital raised
- $55K
- 1 Form D · last Jul 2024
- 27 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 3 pending · first 2026
- Rank in peer group#10 of 27
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$55K
- Federal grantNSF · Phase II · SBIR Phase II: Development of An Allergen-Free Peanut Using Genome Editing Technology$1.2M
- Federal grantNSF · Phase I · SBIR Phase I: Progeny Analysis Of A Chimera-Free Hypoallergenic Peanut$225K
- Federal grantNSF · Phase I · SBIR Phase I: Development of an Allergen-Reduced Peanut for Commercialization$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
97months
from IngateyGen LLC’s first federal award to its first private round.
- First federal award · Jun 2016
- NSF · $225K
- First Form D · Jul 2024
- $55K · 1st Form D
- Awards before first raise
- 3 awards
An association in public records, not a cause or a prediction.
Standing among 27 peers
Line = medianAgritech · Molecule
- Federal grants#6 · top 22%
- Granted patents#10 · top 37%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Hortense DodoResearcherExecutive OfficerLinked by 1 patent · $1.6M in grants as PI
- Koffi KonanExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 4- GrantedPeanut With Reduced Allergen LevelsUSPTOUS 12,559,766
- PendingMethods And Compositions For Modifying Peanut Seed OilUSPTOApplication 19129285
- PendingMethods And Compositions For Modifying Peanut Seed OilUSPTOApplication PCTUS2023079499
Show all 4 patent records
- Peanut With Reduced Allergen LevelsFeb 24, 2026 · US 12,559,766Granted
- Methods And Compositions For Modifying Peanut Seed OilDec 25, 2025 · Application 19129285Pending
- Methods And Compositions For Modifying Peanut Seed OilApplication PCTUS2023079499Pending
- Peanut With Reduced Allergen LevelsApplication PCTUS2018044312Pending
Related companies, and why
- Advanced Biological Marketing, Inc.Similar federal contract value in Agritech · null in contracts
- ROWBOT SYSTEMS LLCSimilar federal contract value in Agritech · null in contracts
- APPLIED LIFESCIENCES & SYSTEMS, LLCSimilar federal contract value in Agritech · null in contracts
- ATLAS AI P.B.C.Similar federal contract value in Agritech · null in contracts
- COSMIC EATS, INC.Similar federal contract value in Agritech · null in contracts
- Daryl StavenessSimilar federal contract value in Agritech · null in contracts
Regulatory activity · Agritech
- Supplemental Disaster Assistance Programs, Marketing Assistance Loans, and Sugar ProvisionsCommodity Credit Corporation
- Revisions to the Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Loan ProgramRural Business-Cooperative Service
- Organic Certification Cost Share Program (OCCSP)Commodity Credit Corporation
- Technical Guidelines for the Production of Regenerative Agricultural Biofuel FeedstocksEnergy and Environmental Policy Office
- Rescinding Portions of U.S. Department of Agriculture Title VI Regulations To Conform More Closely With the Department of Justice's Regulations To Implement Executive Order 14281
- Assistance for Specialty Crop Farmers (ASCF) Program; Approval of Information Collection RequestCommodity Credit Corporation
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .